Skip to main content
Clinical Trials/IRCT20210711051840N1
IRCT20210711051840N1CompletedPhase 3

Comparison of the effectiveness of ketamine and ketorolac infusion to control pain in adult patients

Tehran University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • 1. Age over 18 years
  • 2. Patients with blunt and penetrating trauma, with a fracture of two ribs or more, or patients who need a chest tube insertion.

Exclusion Criteria

  • 1. People who have a history of allergies and drug reactions, especially to ketamine.
  • 2. People with <= 13 GCS
  • 3. People with acute coronary syndrome
  • 4. Increase ICP
  • 5. Severe hypertension (systolic pressure = and 6. People who are currently taking MAO inhibitors.
  • 7. People with a history of psychosis
  • 8. Consumers of psychiatric drugs (Pschycotropic)
  • 9. Active dementia or delirium
  • 10. Glaucoma
  • 11. Pregnancy
  • 12. Inability to express pain or communicate with people
  • 13. Liver failure
  • 14. Patients with active bleeding
  • 15. Patients with gastric ulcer
  • 16. Thrombocytopenia

Investigators

Similar Trials